NCT00887536 2022-04-20A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNSABP Foundation IncPhase 3 Completed1,613 enrolled